Table 4.

Demographic characteristics and functional follow-up parameters of Group 2 (management with only rEMS).

Patient no	Eye	BCVA		FPDI		ERG magnitude
		Time0	Time1	Time0	Time1	Time0	Time1
1	R	100	90	67	60	0.87	0.80
	L	100	90	68	61	0.88	0.81
2	R	65	60	18	16	0.48	0.45
	L	65	60	17	15	0.47	0.43
3	R	50	35	5	3	0.41	0.37
	L	50	35	6	3	0.40	0.37
4	R	100	90	56	54	0.87	0.84
	L	100	90	58	56	0.89	0.87
5	R	90	85	49	47	0.78	0.76
	L	90	85	50	48	0.79	0.78
6	R	60	55	60	54	0.69	0.61
	L	60	55	62	57	0.70	0.62
7	R	75	70	20	18	0.37	0.47
	L	75	70	21	19	0.37	0.48
8	R	35	35	8	5	0.41	0.37
	L	35	35	8	5	0.44	0.40
9	R	90	95	42	40	0.87	1.03
	L	90	95	41	40	0.77	1.20
10	R	85	85	56	55	0.91	0.98
	L	85	85	58	56	0.92	1.01
11	R	50	45	20	18	0.45	0.45
	L	55	50	21	19	0.48	0.47
12	R	85	85	40	38	0.98	0.98
	L	90	85	42	40	0.99	1.20
13	R	100	100	59	59	0.87	1.14
	L	100	100	58	58	0.86	112
14	R	75	75	30	30	0.78	0.96
	L	70	70	28	28	0.74	0.90
15	R	50	35	15	10	0.47	0.37
	L	55	40	17	12	0.51	0.37
16	R	85	80	54	50	0.56	0.54
	L	80	75	51	46	0.52	0.50

Time0 (baseline): just before the Magnovision application.

Time1: 36th month of weekly rEMS sessions.

Abbreviations: BCVA, best corrected visual acuity, (ETDRS letters); ERG magnitudes, full field flicker electroretinography magnitudes (mV); FPDI, fundus perimetry deviation index (%); rEMS, repetitive electromagnetic stimulation.